The etiology of Alzheimer’s disease (AD) and its related dementias (ADRD) is complex. Our existing cohort studies of both AD/ADRD and cognitive aging include social, behavioral, environmental, cognitive, neuroimaging, biomarker, genetic, epigenetic, and other measures assessed longitudinally and collected initially ever earlier in the lifespan. Indeed, it is becoming clear that both risk and protective factors include exposures and experiences in early and mid-life, long before the appearance of any neuropathology or notable cognitive decline. Continued progress in the epidemiology of both AD/ADRD and cognitive resilience is therefore likely to require more diverse and representative cohorts, more participants, more variables, and more occasions of measurement. Additionally, greater collaboration among diverse scientific disciplines will be needed. Moreover, applicants should consider sex as a biological variable.
This notice applies to due dates on or after March 11, 2022 and subsequent receipt dates through November 13, 2024.
Application Due Date(s): March 11, 2022; July 8, 2022; Nov 14, 2022; March 10, 2023; July 10, 2023; Nov 13, 2023; March 11, 2024; July 9, 2024; Nov 12, 2024
NOT-AG-21-045
Sponsor Institute/Organizations: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Nov 12, 2024
Varies
Affiliation: National Institutes of Health
Address: National Institutes of Health; 31 Center Drive; MSC 2220; Bethesda; MD 20892-2220; USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.